Tasimelteon
VP-VEC-162-3502
Phase 3 small_molecule active
Quick answer
Tasimelteon for Sleep Wake Disorders is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Sleep Wake Disorders
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active